Department of Medicine, Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden.
Department of Medicine, Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden.
Lancet Diabetes Endocrinol. 2018 Mar;6(3):197-207. doi: 10.1016/S2213-8587(17)30437-0. Epub 2018 Jan 9.
Bariatric surgery reduces mortality, but might have adverse effects on mental health. We assessed the risk of suicide and self-harm after bariatric surgery compared with non-surgical obesity treatment.
Suicide and non-fatal self-harm events retrieved from nationwide Swedish registers were examined in two cohorts. The non-randomised, prospective Swedish Obese Subjects (SOS) study compared bariatric surgery (n=2010; 1369 vertical-banded gastroplasty, 376 gastric banding, and 265 gastric bypass) with usual care (n=2037; recruitment 1987-2001). The second cohort consisted of individuals from the Scandinavian Obesity Surgery Registry (SOReg; n=20 256 patients who had gastric bypass) matched to individuals treated with intensive lifestyle modification (n=16 162; intervention 2006-13) on baseline BMI, age, sex, education level, diabetes, cardiovascular disease, history of self-harm, substance misuse, antidepressant use, anxiolytics use, and psychiatric health-care contacts.
During 68 528 person-years (median 18; IQR 14-21) in the SOS study, suicides or non-fatal self-harm events were higher in the surgery group (n=87) than in the control group (n=49; adjusted hazard ratio [aHR] 1·78, 95% CI 1·23-2·57; p=0·0021); of these events, nine and three were suicides, respectively (3·06, 0·79-11·88; p=0·11). In analyses by primary procedure type, increased risk of suicide or non-fatal self-harm was identified for gastric bypass (3·48, 1·65-7·31; p=0·0010), gastric banding (2·43, 1·23-4·82; p=0·011), and vertical-banded gastroplasty (2·25, 1·37-3·71; p=0·0015) compared with controls. Out of nine deaths by suicide in the SOS surgery group, five occurred after gastric bypass (two primary and three converted procedures). During 149 582 person-years (median 3·9; IQR 2·8-5·2), more suicides or non-fatal self-harm events were reported in the SOReg gastric bypass group (n=341) than in the intensive lifestyle group (n=84; aHR 3·16, 2·46-4·06; p<0·0001); of these events, 33 and five were suicides, respectively (5·17, 1·86-14·37; p=0·0017). In SOS, substance misuse during follow-up was recorded in 48% (39/81) of patients treated with surgery and 28% (13/47) of controls with non-fatal self-harm events (p=0·023). Correspondingly, substance misuse during follow-up was recorded in 51% (162/316) of participants in the SOReg gastric bypass group and 29% (23/80) of participants in the intensive lifestyle group with non-fatal self-harm events (p=0·0003). The risk of suicide and self-harm was not associated with poor weight loss outcome.
Bariatric surgery was associated with suicide and non-fatal self-harm. However, the absolute risks were low and do not justify a general discouragement of bariatric surgery. The findings indicate a need for thorough preoperative psychiatric history assessment along with provision of information about increased risk of self-harm following surgery. Moreover, the findings call for postoperative surveillance with particular attention to mental health.
US National Institutes of Health and Swedish Research Council.
减重手术可降低死亡率,但可能对心理健康产生不良影响。我们评估了与非手术肥胖治疗相比,减重手术后自杀和自残的风险。
从全国性的瑞典登记处中检索自杀和非致命性自残事件,在两个队列中进行评估。非随机、前瞻性的瑞典肥胖受试者(SOS)研究比较了减重手术(n=2010;1369 例垂直带胃成形术,376 例胃带术,265 例胃旁路术)与常规护理(n=2037;招募时间为 1987-2001 年)。第二个队列由斯堪的纳维亚肥胖手术登记处(SOReg)的患者组成(n=20256 例接受胃旁路术的患者),与接受强化生活方式改变治疗的患者(n=16162 例;干预时间为 2006-13 年)相匹配,匹配的基线 BMI、年龄、性别、教育水平、糖尿病、心血管疾病、自残史、物质滥用、抗抑郁药使用、安定药使用和精神保健接触。
在 SOS 研究的 68528 人年(中位数 18;IQR 14-21)期间,手术组(n=87)的自杀或非致命性自残事件高于对照组(n=49;校正后的危害比[aHR] 1.78,95%CI 1.23-2.57;p=0.0021);其中,分别有 9 例和 3 例为自杀(3.06,0.79-11.88;p=0.11)。在按主要手术类型进行的分析中,胃旁路术(aHR 3.48,1.65-7.31;p=0.0010)、胃带术(aHR 2.43,1.23-4.82;p=0.011)和垂直带胃成形术(aHR 2.25,1.37-3.71;p=0.0015)的自杀或非致命性自残风险增加。在 SOS 手术组的 9 例自杀死亡中,5 例发生在胃旁路术后(2 例为原发性,3 例为转换性手术)。在 149582 人年(中位数 3.9;IQR 2.8-5.2)期间,SOReg 胃旁路术组报告的自杀或非致命性自残事件多于强化生活方式组(n=341;aHR 3.16,2.46-4.06;p<0.0001);其中,分别有 33 例和 5 例为自杀(5.17,1.86-14.37;p=0.0017)。在 SOS 中,手术组有 48%(39/81)的患者在随访期间有物质滥用,对照组有非致命性自残事件的患者有 28%(13/47)(p=0.023)。相应地,在 SOReg 胃旁路术组中,有 51%(162/316)的参与者在随访期间有物质滥用,而在强化生活方式组中,有非致命性自残事件的参与者有 29%(23/80)(p=0.0003)。自杀和自残的风险与减肥效果不佳无关。
减重手术与自杀和非致命性自残有关。然而,绝对风险较低,不应普遍劝阻进行减重手术。这些发现表明,需要在手术前彻底评估精神病史,并提供关于手术后自残风险增加的信息。此外,这些发现还需要进行术后监测,特别注意心理健康。
美国国立卫生研究院和瑞典研究理事会。